Medlabs quarterly activity today. The market will wake up to Cronos/CDA health soon. Can't wait to see a full Cronos quarterly since CDA health has come along, hopefully some more free cash flow.
Key Financial highlights:
• Cash receipts from customers amounted to $0.9m for the quarter, reflecting improved operating revenues of $1.3M
• The month of March cash burn was $0.3M with the March quarter cash burn at $2.6M
• Cash position as at end of March 2022 was $8.6M, with sufficient cash and significant global partnering opportunities anticipated to generate revenue, supporting future cash flow
• Confirmed ~$5M cash receipts from revenues for balance of calendar year 2022, excluding any potential partnering deals Medlab is currently working on
• 70+ partnering engagements to which five partnership agreements are in discussions/term sheet generation
ASX Cannabis Players, page-12
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
